在颅咽管瘤后患有下丘脑性肥胖的患者中，利拉鲁肽3毫克作为减肥手术失败后的一种减肥策略。 - Suppr | 超能文献

相似文献

1

Liraglutide 3mg as a weight-loss strategy after failed bariatric surgery in a patient with hypothalamic obesity following craniopharyngioma.在颅咽管瘤后患有下丘脑性肥胖的患者中，利拉鲁肽3毫克作为减肥手术失败后的一种减肥策略。

Diabetes Metab. 2020 Nov;46(6):514-515. doi: 10.1016/j.diabet.2019.07.004. Epub 2019 Jul 27.

2

Management of Hypothalamic Obesity.下丘脑性肥胖的管理。

Endocrinol Metab Clin North Am. 2020 Sep;49(3):533-552. doi: 10.1016/j.ecl.2020.05.009. Epub 2020 Jul 15.

3

Risk Factors for Hypothalamic Obesity in Patients With Adult-Onset Craniopharyngioma: A Consecutive Series of 120 Cases.成人颅咽管瘤患者发生下丘脑性肥胖的危险因素：连续 120 例病例系列。

Front Endocrinol (Lausanne). 2021 Jul 28;12:694213. doi: 10.3389/fendo.2021.694213. eCollection 2021.

4

Hypothalamic obesity after craniopharyngioma surgery: Treatment with a long acting glucagon like peptide 1 derivated.

Endocrinol Diabetes Nutr. 2017 Mar;64(3):182-184. doi: 10.1016/j.endinu.2016.10.006. Epub 2017 Feb 27.

5

Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: a matched case-control study with 2 years of follow-up.减肥手术治疗颅咽管瘤相关性下丘脑性肥胖的疗效与安全性：一项为期2年随访的配对病例对照研究

Int J Obes (Lond). 2017 Feb;41(2):210-216. doi: 10.1038/ijo.2016.195. Epub 2016 Oct 31.

6

Childhood craniopharyngioma - current status and recent perspectives in diagnostics and treatment.儿童颅咽管瘤——诊断与治疗的现状及最新观点

J Pediatr Endocrinol Metab. 2015 Jan;28(1-2):1-2. doi: 10.1515/jpem-2014-0416.

7

Is bariatric surgery really inefficient in hypothalamic obesity?减肥手术在下丘脑性肥胖中真的无效吗？

Clin Endocrinol (Oxf). 2013 Apr;78(4):636-8. doi: 10.1111/cen.12031.

8

Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity.颅咽管瘤与下丘脑损伤：对随之而来的饮食失调和肥胖的最新见解

Curr Opin Endocrinol Diabetes Obes. 2016 Feb;23(1):81-9. doi: 10.1097/MED.0000000000000214.

9

Bariatric Surgery for Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy: a Matched Case-Control Study.颅咽管瘤治疗后下丘脑肥胖的减重手术治疗：一项匹配病例对照研究。

Obes Surg. 2020 Jun;30(6):2439-2444. doi: 10.1007/s11695-020-04391-w.

10

Bariatric Interventions in Craniopharyngioma Patients-Best Choice or Last Option for Treatment of Hypothalamic Obesity?颅咽管瘤患者的减重干预——治疗下丘脑性肥胖的最佳选择还是最后选择？

J Clin Endocrinol Metab. 2022 Jan 1;107(1):e426-e428. doi: 10.1210/clinem/dgab567.

引用本文的文献

1

Treatment of Hypothalamic Obesity With GLP-1 Analogs.使用胰高血糖素样肽-1类似物治疗下丘脑性肥胖。

J Endocr Soc. 2024 Nov 14;9(1):bvae200. doi: 10.1210/jendso/bvae200. eCollection 2024 Nov 26.

2

Semaglutide treatment of hypothalamic obesity - a real-life data study.司美格鲁肽治疗下丘脑性肥胖 - 真实世界数据研究。

Pituitary. 2024 Oct;27(5):685-692. doi: 10.1007/s11102-024-01429-5. Epub 2024 Aug 9.

3

Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications.超越减肥：附加益处或可指导抗肥胖药物的选择。